Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, Jose van den Berg, Koen K. van de Vijver, Karolina Sikorska, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O. Nielsen, Sunil S. Badve, Stefan Michiels, William Fraser Symmans, Christos Sotiriou, David L. Rimm, Stephen M. Hewitt, Carsten Denkert, Sibylle LoiblSherene Loi, John M. S. Bartlett, Giancarlo Pruneri, Deborah A. Dillon, Maggie C. U. Cheang, Andrew Tutt, Jacqueline A. Hall, Zuzana Kos, Roberto Salgado*, Marleen Kok, Hugo M. Horlings, International Immuno-Oncology Biomarker Working Group

*Corresponding author for this work

    Research output: Contribution to journal › Review article › peer-review

    15 Citations (Scopus)
    51 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials'. Together they form a unique fingerprint.

    Medicine & Life Sciences